NCT06850389 PMCF Investigation of Medical Device ChitoCare® Medical
| NCT ID | NCT06850389 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Primex ehf |
| Condition | Dermatitis |
| Study Type | OBSERVATIONAL |
| Enrollment | 214 participants |
| Start Date | 2025-06-11 |
| Primary Completion | 2025-12 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 214 participants in total. It began in 2025-06-11 with a primary completion date of 2025-12.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This is a post-marketing observational clinical investigation conducted as part of the post-market clinical follow-up of ChitoCare® Medical, aimed to confirm safety and efficacy according to the requirements of Regulation (EU) 2017/745 of the European Parliament and of the Council of 5 April 2017 on medical devices, for the following indications: Gel - scars, conditions after dermatosurgical procedures, dermatitis, acne Spray - conditions after dermatosurgical procedures, dermatitis, acne
Eligibility Criteria
The inclusion criteria are fully according to indications: * Gel - scars, conditions after dermatosurgical procedures, dermatitis, acne * Spray - conditions after dermatosurgical procedures, dermatitis, acne The criteria for exclusion are fully according to contraindications: * Allergy to any of the ingredients of the product
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06850389 clinical trial?
This trial is open to participants of all sexes, studying Dermatitis. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06850389 currently recruiting?
Yes, NCT06850389 is actively recruiting participants. Contact the research team at craig@chitocare.com for enrollment information.
Where is the NCT06850389 trial being conducted?
This trial is being conducted at Prague, Czechia, Prague, Czechia.
Who is sponsoring the NCT06850389 clinical trial?
NCT06850389 is sponsored by Primex ehf. The trial plans to enroll 214 participants.